A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: ViiV Healthcare
• Collaborator: Pfizer
• Treatments: Maraviroc; Raltegravir Potassium

Criteria

Inclusion Criteria:

• Healthy male and/or female subjects between 18 and 55 years of age.

Exclusion Criteria:

• Evidence or history of clinically significant disease or clinical findings at screening